InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Wednesday, 07/08/2020 7:45:17 AM

Wednesday, July 08, 2020 7:45:17 AM

Post# of 1253
News: $ABEO Abeona Therapeutics Reinitiates Enrollment in EB-101 Pivotal Phase 3 VIITAL(TM) Study in RDEB after COVID-19 Related Pause and Announces Progress in Patient Enrollment in MPS III Studies

NEW YORK and CLEVELAND, July 08, 2020 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced recent updates on its clinical programs, highlighted by the restart of patient enrollment in the Company’s pivotal Ph...

Read the whole news ABEO - Abeona Therapeutics Reinitiates Enrollment in EB-101 Pivotal Phase 3 VIITAL(TM) Study in RDEB after COVID-19 Related Pause and Announces Progress in Patient Enrollment in MPS III Studies
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABEO News